654 related articles for article (PubMed ID: 9752982)
1. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
2. Barrett's esophagus and medications that relax the lower esophageal sphincter.
Corley DA; Levin TR; Habel LA; Buffler PA
Am J Gastroenterol; 2006 May; 101(5):937-44. PubMed ID: 16573773
[TBL] [Abstract][Full Text] [Related]
3. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.
Vaughan TL; Davis S; Kristal A; Thomas DB
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):85-92. PubMed ID: 7742727
[TBL] [Abstract][Full Text] [Related]
4. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.
Wu AH; Tseng CC; Bernstein L
Cancer; 2003 Sep; 98(5):940-8. PubMed ID: 12942560
[TBL] [Abstract][Full Text] [Related]
5. Occupation and risk of esophageal and gastric cardia adenocarcinoma.
Engel LS; Vaughan TL; Gammon MD; Chow WH; Risch HA; Dubrow R; Mayne ST; Rotterdam H; Schoenberg JB; Stanford JL; West AB; Blot WJ; Fraumeni JF
Am J Ind Med; 2002 Jul; 42(1):11-22. PubMed ID: 12111686
[TBL] [Abstract][Full Text] [Related]
6. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
[TBL] [Abstract][Full Text] [Related]
7. Nutrient intake and risk of subtypes of esophageal and gastric cancer.
Mayne ST; Risch HA; Dubrow R; Chow WH; Gammon MD; Vaughan TL; Farrow DC; Schoenberg JB; Stanford JL; Ahsan H; West AB; Rotterdam H; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1055-62. PubMed ID: 11588131
[TBL] [Abstract][Full Text] [Related]
8. Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
Duan L; Wu AH; Sullivan-Halley J; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):526-33. PubMed ID: 19190141
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
Lagergren J; Bergström R; Lindgren A; Nyrén O
N Engl J Med; 1999 Mar; 340(11):825-31. PubMed ID: 10080844
[TBL] [Abstract][Full Text] [Related]
10. Perinatal risk factors for cancer of the esophagus and gastric cardia: a nested case-control study.
Akre O; Forssell L; Kaijser M; Norén-Nilsson I; Lagergren J; Nyrén O; Ekbom A
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):867-71. PubMed ID: 16702362
[TBL] [Abstract][Full Text] [Related]
11. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study.
Lindblad M; Rodríguez LA; Lagergren J
Cancer Causes Control; 2005 Apr; 16(3):285-94. PubMed ID: 15947880
[TBL] [Abstract][Full Text] [Related]
12. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States.
Kubo A; Corley DA
Cancer; 2002 Nov; 95(10):2096-102. PubMed ID: 12412162
[TBL] [Abstract][Full Text] [Related]
13. [Increased incidence of adenocarcinoma of the esophagus and cardia. Reflux and obesity are strong and independent risk factors according to the SECC study].
Lagergren J
Lakartidningen; 2000 Apr; 97(16):1950-3. PubMed ID: 10826353
[TBL] [Abstract][Full Text] [Related]
14. Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia.
Terry P; Lagergren J; Wolk A; Nyrén O
Nutr Cancer; 2000; 38(2):186-91. PubMed ID: 11525596
[TBL] [Abstract][Full Text] [Related]
15. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma.
Lagergren J; Bergström R; Adami HO; Nyrén O
Ann Intern Med; 2000 Aug; 133(3):165-75. PubMed ID: 10906830
[TBL] [Abstract][Full Text] [Related]
16. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.
Chow WH; Blaser MJ; Blot WJ; Gammon MD; Vaughan TL; Risch HA; Perez-Perez GI; Schoenberg JB; Stanford JL; Rotterdam H; West AB; Fraumeni JF
Cancer Res; 1998 Feb; 58(4):588-90. PubMed ID: 9485003
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
Duan L; Wu AH; Sullivan-Halley J; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):126-34. PubMed ID: 18187391
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drugs, lower oesophageal sphincter-relaxing drugs and oesophageal cancer. A case-control study.
Ranka S; Gee JM; Johnson IT; Skinner J; Hart AR; Rhodes M
Digestion; 2006; 74(2):109-15. PubMed ID: 17167266
[TBL] [Abstract][Full Text] [Related]
19. Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers.
Fortuny J; Johnson CC; Bohlke K; Chow WH; Hart G; Kucera G; Mujumdar U; Ownby D; Wells K; Yood MU; Engel LS
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1154-1159.e3. PubMed ID: 17644046
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors.
Zhang ZF; Kurtz RC; Sun M; Karpeh M; Yu GP; Gargon N; Fein JS; Georgopoulos SK; Harlap S
Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):761-8. PubMed ID: 8896886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
